Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.7445
-0.0627 (-7.77%)
At close: May 4, 2026, 4:00 PM EDT
0.7599
+0.0154 (2.07%)
After-hours: May 4, 2026, 7:44 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $10.04 million as of May 4, 2026. Its market cap has decreased by -18.04% in one year.
Market Cap
10.04M
Enterprise Value
21.51M
1-Year Change
-18.04%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $10.04M, a decrease of -90.30%. That is a compound annual growth rate of -35.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 10.89M | -40.34% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trinity Biotech | 11.59M |
| Sintx Technologies | 9.91M |
| Tenon Medical | 8.54M |
| Nexalin Technology | 7.83M |
| Beyond Air | 7.61M |
| enVVeno Medical | 7.00M |
| Biomerica | 6.71M |
| HeartSciences | 6.50M |